Perjeta, which is pertuzumab, represents a significant advancement in managing HER2-positive breast cancer. The medication works by targeting a distinct pathway which helps cancer cells grow . In contrast to some alternative HER2-targeted therapies, pertuzumab doesn't directly block the HER2 recepto